Physician profile
Kendale E Speyerer
NPI 1518619758
$705.68
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $126 · 2023: $415 · 2024: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $150.99 | 2024 | Hemoblast Bellows |
| Davol INC. | $146.96 | 2023 | Phasix Mesh |
| Medtronic, INC. | $145.52 | 2022-2023 | Signia |
| Boston Scientific Corporation | $136.29 | 2023 | Watchman Access System |
| Intuitive Surgical, INC. | $44.02 | 2022 | |
| Janssen Biotech, INC. | $42.12 | 2023 | Stelara, Simponi Aria, Simponi |
| Abbvie INC. | $26.19 | 2023-2024 | |
| Kci USA, INC. | $13.59 | 2023 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendale Speyerer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.